Lipids and the pathogenesis of Alzheimer's disease: Is there a link?
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in International Review of Psychiatry
- Vol. 18 (2) , 173-186
- https://doi.org/10.1080/09540260600583007
Abstract
Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder characterized pathologically by amyloid-beta plaques, neurofibrillary tangles and neuronal loss. Its fundamental cause(s) and the pathological cascades leading to clinical symptoms remain unknown. Lipids and lipid peroxidation products have important roles in the homeostasis of the central nervous system. As well, lipid transport genes and vascular changes associated with peripheral dyslipidemia have been associated with an increased risk of AD. The present review discusses ways in which lipids may be involved in the pathogenesis of AD-associated neurodegeneration through their roles as neuronal structural components, cell modulators, or second messengers. Given the many possibilities through which lipids may be directly involved in or contribute to the pathogenesis of AD, the use of lipids as biomarkers for disease progression is discussed, as are other avenues for future research.Keywords
This publication has 98 references indexed in Scilit:
- Global prevalence of dementia: a Delphi consensus studyPublished by Elsevier ,2006
- The Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineJAMA, 2004
- Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer’s diseaseNeuroscience Letters, 2004
- Smith‐Lemli‐Opitz Syndrome and the DHCR7 GeneAnnals of Human Genetics, 2003
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- The role of glutathione, membrane sphingomyelin, and its metabolites in oxidative stress-induced calcium “dysregulation” in PC12 cellsFree Radical Biology & Medicine, 1999
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroNature, 1995
- An update of the enzymology and regulation of sphingomyelin metabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Inhibition of Atherosclerosis by Cod-Liver Oil in a Hyperlipidemic Swine ModelNew England Journal of Medicine, 1986